The biotech market in the United States is experiencing a substantial surge in demand for Tirzepatide APIs. This potent medication, used to treat insulin resistance, has gained remarkable attention from both patients and doctors. As a result, numerous companies have emerged as producers of Tirzepatide APIs in the USA. Well-known Tirzepatide API